Bill > SB00434

This bill aims to modify existing state statutes to allow compounding pharmacies (specialized pharmacies that can create custom medications) to produce active pharmaceutical ingredients for specific drugs. The bill specifically mentions enabling the compounding of drugs like levonorgestrel, mifepristone, and misoprostol, which are commonly used in reproductive healthcare. By explicitly permitting the compounding of these active ingredients, the legislation seeks to improve access to these medications, potentially in response to potential supply chain disruptions or limitations in drug availability. The bill does not provide extensive details about the technical or regulatory specifics of how compounding pharmacies will implement these provisions, but it clearly establishes a legal framework to support their ability to create these pharmaceutical ingredients when needed.

Justice

https://www.cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&bill_num=SB00434&which_year=2025